23andMe is teaming up with GlaxoSmithKline
It'll essentially have a monopoly on the wealth of information 23andMe has collected since its inception. https://t.co/Dqcngdl7MF
— Futurism (@futurism) July 26, 2018
It'll essentially have a monopoly on the wealth of information 23andMe has collected since its inception. https://t.co/Dqcngdl7MF
— Futurism (@futurism) July 26, 2018